We are live on ! Find out more
KB

Kimelman & Baird Portfolio holdings

AUM $1.22B
1-Year Est. Return 11.47%
This Fund
S&P 500
This Quarter Est. Return
-2.9%
1 Year Est. Return
+11.47%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.22B
AUM Growth
-$86.4M
Cap. Flow
-$26.2M
Cap. Flow %
-2.15%
Top 10 Hldgs %
42.8%
Holding
275
New
12
Increased
27
Reduced
50
Closed
12

Sector Composition

Rank Sector Weight
1 Industrials 20.74%
2 Financials 18.47%
3 Technology 18.41%
4 Consumer Discretionary 15.76%
5 Healthcare 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KD icon
251
Kyndryl
KD
$2.66B
$525 ﹤0.01%
40
IQV icon
252
IQVIA
IQV
$34.7B
$512 ﹤0.01%
3
URNM icon
253
Sprott Uranium Miners ETF
URNM
$1.78B
$443 ﹤0.01%
7
AMD icon
254
Advanced Micro Devices
AMD
$851B
$407 ﹤0.01%
2
LBTYK icon
255
Liberty Global Class C
LBTYK
$3.25B
$352 ﹤0.01%
30
GEHC icon
256
GE HealthCare
GEHC
$27.6B
$285 ﹤0.01%
4
LUMN icon
257
Lumen
LUMN
$6.53B
$237 ﹤0.01%
34
XRX icon
258
Xerox
XRX
$337M
$65 ﹤0.01%
50
XP icon
259
XP
XP
$8.62B
$58 ﹤0.01%
3
NOK icon
260
Nokia
NOK
$50.8B
$33 ﹤0.01%
4
IJK icon
261
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
0
GPRO icon
262
GoPro
GPRO
$116M
$20 ﹤0.01%
25
XRXDW
263
Xerox Holdings Corp Warrants
XRXDW
$16M
$3 ﹤0.01%
+25
New +$3
CC icon
264
Chemours
CC
$2.59B
-100
Closed -$1.18K
CDW icon
265
CDW
CDW
$17.1B
-250
Closed -$34K
EL icon
266
Estee Lauder
EL
$29B
-300
Closed -$31.4K
EXAS
267
DELISTED
Exact Sciences
EXAS
-1,997
Closed -$203K
FISV
268
Fiserv Inc
FISV
$27.2B
-400
Closed -$26.9K
INTU icon
269
Intuit
INTU
$81.1B
-75
Closed -$49.7K
MOS icon
270
The Mosaic Company
MOS
$7.09B
-1,200
Closed -$28.9K
ROP icon
271
Roper Technologies
ROP
$36.3B
-75
Closed -$33.4K
MRP
272
Millrose Properties Inc
MRP
$4.74B
-412
Closed -$12.3K

Similar funds

Kimelman & Baird's Q1 2026 Portfolio in Review

As of Q1 2026, Kimelman & Baird held 275 positions worth $1.22B, down 6.6% from $1.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Kimelman & Baird's Q1 2026 filing shows 12 new, 27 increased, 50 reduced and 12 closed positions. Its largest new stake was Travelers Companies: 8,514 shares worth $2.48M. The largest sale was Norfolk Southern, an estimated $16.9M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

  • Kimelman & Baird's largest Q1 2026 buy was Travelers Companies: 8,514 shares worth $2.48M.
  • Kimelman & Baird added most to Regeneron Pharmaceuticals in Q1 2026, an estimated $8.07M increase.
  • Kimelman & Baird's biggest Q1 2026 reduction was Norfolk Southern, cutting an estimated $16.9M.
  • Kimelman & Baird fully exited Exact Sciences in Q1 2026, selling an estimated $203K.
  • Kimelman & Baird's ten largest holdings make up 43% of its $1.22B portfolio in Q1 2026.
  • Kimelman & Baird opened 12 new positions and closed 12 in Q1 2026.
  • Kimelman & Baird's portfolio value fell 6.6% quarter-over-quarter to $1.22B.

Based on Kimelman & Baird's 13F filing for Q1 2026, filed 13 May 2026.